Developing-country vaccine manufacturers’ technical capabilities can make a difference in global immunization
- 1 August 2021
- Vol. 39 (36) , 5153-5161
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Two decades of vaccine innovations for global public good: Report of the Developing Countries’ Vaccine Manufacturers Network 20th meeting, 21–23 october 2019, Rio de Janeiro, BrazilVaccine, 2020
- Emerging vaccine manufacturers are innovating for the next decadeVaccine: X, 2020
- Emerging manufacturers engagements in the COVID −19 vaccine research, development and supplyVaccine, 2020
- The socio-economic implications of the coronavirus pandemic (COVID-19): A reviewInternational Journal of Surgery, 2020
- International Public Health Responses to COVID-19 Outbreak: A Rapid Review2020
- The COVID-19 vaccine development landscapeNature Reviews Drug Discovery, 2020
- Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogensMolecular Therapy - Methods & Clinical Development, 2016
- Pichia pastoris as an expression host for membrane protein structural biologyCurrent Opinion in Structural Biology, 2015
- The contribution of vaccination to global health: past, present and futurePhilosophical Transactions of the Royal Society B: Biological Sciences, 2014
- Adenoviral Producer CellsViruses, 2010